Silvia Mateo Lozano

Investigador

Research group

Prada-Varela E, Táboas-Outón P, Andrades E, Gomez-Gonzalez S, Mateo-Lozano S, Cebrià A, Berenguer-Molins P, Perera-Bel J, Arcon JP, Saen-Oon S, Díaz L, Gay M, Folch-I-Casanovas I, Odena A, Vilaseca M, Rovira Q, García-Gerique L, Rodriguez E, Rovira-Zurriaga C, Rodrigues G, Carcaboso AM, Avgustinova A, Hernandez-Muñoz MI and Mora J PRKG1 hinders myogenic differentiation and predicts response to AKT inhibitor ipatasertib in Rhabdomyosarcoma. NATURE COMMUNICATIONS 2025. 16(1): 9816-9816.
Chicón-Bosch, M, Sánchez-Serra, S, Rosàs-Lapeña, M, Costa-Fraga, N, Besalú-Velázquez, J, Illa-Bernadí, J, Mateo-Lozano S, Cidre-Aranaz, F, Grünewald, TGP, Díaz-Lagares, A, Lopez-Alemany, R and Tirado, OM Multi-omics profiling reveals key factors involved in Ewing sarcoma metastasis MOLECULAR ONCOLOGY 2025. 19(4): 1002-1028.
Figuerola-Bou E, Rios-Astorch C, Blanco E, Sanchez-Jimenez M, Táboas-Outón P, Fernandez-Isern G, Gomez-Gonzalez S, Muñoz-Aznar O, Castellano P, Pérez-Jaume S, Prada-Varela E, Mateo-Lozano S, Riggi N, Avgustinova A, Lavarino C, Di Croce L, Sánchez-Molina S and Mora J KDM6 demethylases mediate EWSR1-FLI1-driven oncogenic transformation in Ewing Sarcoma Biorxiv 2023. : .

More Publications

Project name:: Molecular analysis of the metastatic process in developmental tumors
Leader: Silvia Mateo Lozano
Funding entities:: Fundació La Marató de TV3
Code: 201925-31
Starting - finishing date:: 2020 - 2023

Project name:: Terapias combinadas para neuroblastoma basadas en el receptor-sensor de calcio
Leader: Carmen De Torres Gómez-Pallete
Funding entities:: Instituto de Salud Carlos III (ISCIII)
Code: PI17/00350
Starting - finishing date:: 2018 - 2018

More projects

More activities